诺瓦瓦克斯医药(NVAX)股价今日盘中大涨11.89%,引发市场关注。
此前美国路易斯安那州报告出现首例人感染H5N1型高致病性禽流感病毒死亡病例。疾控中心数据显示,去年四季度美国多个州份呼吸道疾病活跃水平较高,包括流感等。
这一消息引发市场对流感疫苗需求的担忧,推高了诺瓦瓦克斯医药等疫苗企业股价。作为专注疫苗研发的生物技术公司,诺瓦瓦克斯有望受益于疫苗需求的上升。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.